STMNZ Stock Overview
Provides tooth replacement and orthodontic solutions worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Straumann Holding AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF 111.30 |
| 52 Week High | CHF 151.50 |
| 52 Week Low | CHF 103.75 |
| Beta | 1.25 |
| 11 Month Change | -12.29% |
| 3 Month Change | -11.17% |
| 1 Year Change | -8.55% |
| 33 Year Change | -42.73% |
| 5 Year Change | n/a |
| Change since IPO | 636.60% |
Recent News & Updates
Recent updates
Shareholder Returns
| STMNZ | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | 0.7% | -0.2% | 1.7% |
| 1Y | -8.5% | -2.3% | 8.3% |
Return vs Industry: STMNZ underperformed the UK Medical Equipment industry which returned -2.3% over the past year.
Return vs Market: STMNZ underperformed the UK Market which returned 8.3% over the past year.
Price Volatility
| STMNZ volatility | |
|---|---|
| STMNZ Average Weekly Movement | 4.3% |
| Medical Equipment Industry Average Movement | 6.3% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 10.3% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: STMNZ has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: STMNZ's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1954 | 11,145 | Guillaume Daniellot | www.straumann.com |
Straumann Holding AG provides tooth replacement and orthodontic solutions worldwide. It researches, develops, manufactures, and supplies dental implants, instruments, CADCAM prosthetics, orthodontic aligners, biomaterials, and digital solutions for use in tooth correction, replacement, and restoration, as well as to prevent tooth loss. The company offers dental implants and components made from titanium, titanium alloy, and ceramics; prosthetic elements made od ceramics, metal or polymer; and clear aligners.
Straumann Holding AG Fundamentals Summary
| STMNZ fundamental statistics | |
|---|---|
| Market cap | CHF 17.78b |
| Earnings (TTM) | CHF 287.88m |
| Revenue (TTM) | CHF 2.54b |
61.8x
P/E Ratio7.0x
P/S RatioIs STMNZ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| STMNZ income statement (TTM) | |
|---|---|
| Revenue | CHF 2.54b |
| Cost of Revenue | CHF 694.02m |
| Gross Profit | CHF 1.85b |
| Other Expenses | CHF 1.56b |
| Earnings | CHF 287.88m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Feb 19, 2025
| Earnings per share (EPS) | 1.81 |
| Gross Margin | 72.69% |
| Net Profit Margin | 11.33% |
| Debt/Equity Ratio | 12.6% |
How did STMNZ perform over the long term?
See historical performance and comparison